<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63659">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01772537</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00067716</org_study_id>
    <secondary_id>5KL2RR025006</secondary_id>
    <nct_id>NCT01772537</nct_id>
  </id_info>
  <brief_title>The Effects of Anethesia on Patients Undergoing Surgery for Repair of a Thoracoabdominal Aneurysm.</brief_title>
  <official_title>The Effect of Anesthesia on Potential CSF and Serum Markers of Alzheimer's Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <authority>United States: The Johns Hopkins University Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alzheimer's disease represents a growing public health problem in developed countries.
      Although the pathogenesis is not clearly defined, accumulation of extracellular amyloid,
      neurofibrillary tangles and neuronal loss are the hallmarks of Alzheimer's disease. The
      effect of anesthetic agents on changes in these proteins in humans is not well
      characterized, but in-vitro evidence suggests that anesthetic agents can accelerate
      potential pathogenic mechanisms, such as increasing amyloid formation or rates of apoptosis
      in cultured cells and increasing amyloid levels in mice. Human data on the effect of
      anesthetic agents on amyloid and tau proteins is limited to a small series of 11 patients
      and showed a significant increase in tau levels after exposure to anesthetics. In this study
      we propose to measure CSF and serum biomarkers in a population of patients with normal CSF
      dynamics, who are undergoing surgery for repair of a thoracoabdominal aneurysm. We will also
      obtain preliminary data on whether changes in CSF levels of these proteins are associated
      with postoperative delirium or cognitive change.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Changes in CSF levels of tau and amyloid</measure>
    <time_frame>48 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delirium and cognitive change</measure>
    <time_frame>48 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Serum inflammatory markers</measure>
    <time_frame>48 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Open Thoracoabdominal Aneurysm Repair</condition>
  <condition>Thoracoabdominal Aneursym Stent</condition>
  <condition>Thoracoabdominal Aneursym Repair With Cardiopulmonary Bypass</condition>
  <condition>Abdominal Aneurysm</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous anesthetic - patients will be induced with 1-2mg/kg of Propofol and maintained with 25-200 mcg/kg/min of Propofol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard of care anesthetic - patients will be induced with 1-2 mg/kg of propofol and maintained with 0.5%-1.5% of isoflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Intravenous anesthetic</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>isoflurane</intervention_name>
    <arm_group_label>Isoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 21-100 years of age

          -  Patients presenting for surgical repair of a thoracoabdominal aneursym

          -  Insertion of a CSF spinal drain for clinically indicated reason

        Exclusion Criteria:

          -  Patients with pre-existing delirium

          -  Inability to speak and understand English

          -  Severe hearing impairment, resulting in inablility to converse

          -  Pregnancy. Pregnancy status will be assesed using a serum pregnancy test during
             preoperative evaluation as part of the standard  of care.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charles Brown, MD</last_name>
    <phone>410-955-0994</phone>
    <email>cbrown12@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mirinda Anderson White, RN</last_name>
    <phone>410-955-6488</phone>
    <email>mander47@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Brown, MD</last_name>
      <phone>410-955-0994</phone>
      <email>cbrown12@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mirinda Anderson White, RN</last_name>
      <phone>410-955-6488</phone>
      <email>mander47@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ahbay Moghekar, M.B.B.S</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Black, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 17, 2013</lastchanged_date>
  <firstreceived_date>January 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Charles Brown, MD</investigator_full_name>
    <investigator_title>Charles Brown, MD</investigator_title>
  </responsible_party>
  <keyword>thoracoabdominal</keyword>
  <keyword>aneurysm</keyword>
  <keyword>open</keyword>
  <keyword>stent</keyword>
  <keyword>cardiopulmonary</keyword>
  <keyword>abdominal</keyword>
  <keyword>bypass</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Anesthetics, Intravenous</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
